The Role of MicroRNAs in Ovarian Cancer

Table 1

Potential prognostic miRs for ovarian cancer, which are significant in multivariate analysis (modified from [27]).

Reference	microRNA	Patients	Prognosis	Endpoint
[29], 2013	miR-21 (Serum)	EOC	Poor	OS
[30], 2014	miR-25	EOC	Poor	OS
[31], 2009	miR-29b	SAC	Poor	DFS
[32], 2012	miR-100	EOC	Good	OS
[33], 2014	miR-150	EOC	Good	PFS, OS
[34], 2012	miR-187	EOC	Good	RFS, OS
[35], 2009	miR-200a	EOC	Good	RFS, OS
[28], 2011	miR-200c	EOC (Stage 1)	Good	PFS, OS
[36], 2013	miR-203	EOC	Poor	PFS, OS
[37], 2013	miR-221	EOC	Poor	OS
[38], 2010	miR-221/222 ratio	EOC	Good	OS
[39], 2014	miR-335	EOC	Good	RFS, OS
[40], 2011	miR-410 and miR-645	EOC	Good	OS

EOC: epithelial ovarian cancer; SAC: serous adenocarcinoma; OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; RFS: recurrent-free survival.